| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $210.8M | +63.4% |
| R&D Expense | $125.3M | +25.5% |
| SG&A Expense | $38.5M | +19.1% |
| Operating Income | $47.0M | +1586.7% |
| Income Tax | $859K | -95.4% |
| Net Income | $65.6M | +1081.7% |
| EPS (Basic) | $1.76 | +980.0% |
| EPS (Diluted) | $1.68 | +940.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.2M | +49.7% |
| Current Assets | $440.0M | +19.0% |
| Total Assets | $526.3M | +12.2% |
| Current Liabilities | $39.5M | -75.1% |
| Total Liabilities | $97.6M | -57.0% |
| Stockholders' Equity | $428.7M | +76.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.6M | -129.7% |
| Capital Expenditures | $3.2M | -43.7% |
| Investing Cash Flow | -$27.8M | +79.9% |
| Financing Cash Flow | $103.0M | +389.4% |
| Free Cash Flow | -$44.7M | -133.3% |